This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y
12
receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XI, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds according to Formulae I and III-XI.
本发明涉及一种预防或治疗与血小板聚集相关的疾病或病症的方法。该方法还涉及一种治疗血栓形成或相关疾病的方法。该方法包括向受试者注射含有有效量的非核苷酸化合物的药物组成物,优选为P2Y12受体拮抗剂化合物,其中所述量足以抑制血小板聚集。本发明所用于此目的的化合物包括公式I和III-XI的化合物,或其盐、
水合物和溶剂化物。本发明还提供了公式I和III-XI的新型化合物。